These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 33002736)

  • 1. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
    Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
    Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining penems.
    Dalhoff A; Janjic N; Echols R
    Biochem Pharmacol; 2006 Mar; 71(7):1085-95. PubMed ID: 16413506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.
    González-Bello C; Rodríguez D; Pernas M; Rodríguez Á; Colchón E
    J Med Chem; 2020 Mar; 63(5):1859-1881. PubMed ID: 31663735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamases and beta-lactamase inhibitors.
    Williams JD
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
    Gehlot P; P H
    Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.
    Liu B; Trout REL; Chu GH; McGarry D; Jackson RW; Hamrick JC; Daigle DM; Cusick SM; Pozzi C; De Luca F; Benvenuti M; Mangani S; Docquier JD; Weiss WJ; Pevear DC; Xerri L; Burns CJ
    J Med Chem; 2020 Mar; 63(6):2789-2801. PubMed ID: 31765155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faropenem reacts with serine and metallo-β-lactamases to give multiple products.
    Lucic A; Hinchliffe P; Malla TR; Tooke CL; Brem J; Calvopiña K; Lohans CT; Rabe P; McDonough MA; Armistead T; Orville AM; Spencer J; Schofield CJ
    Eur J Med Chem; 2021 Apr; 215():113257. PubMed ID: 33618159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Extensive Review on β-lactamase Enzymes and their Inhibitors.
    Agarwal V; Tiwari A; Varadwaj P
    Curr Med Chem; 2023; 30(7):783-808. PubMed ID: 35726414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
    Bebrone C; Lassaux P; Vercheval L; Sohier JS; Jehaes A; Sauvage E; Galleni M
    Drugs; 2010 Apr; 70(6):651-79. PubMed ID: 20394454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of β-Lactamases. New Life of β-Lactam Antibiotics.
    Egorov AM; Ulyashova MM; Rubtsova MY
    Biochemistry (Mosc); 2020 Nov; 85(11):1292-1309. PubMed ID: 33280574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
    Buynak JD
    Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
    Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
    Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
    Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
    J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three decades of beta-lactamase inhibitors.
    Drawz SM; Bonomo RA
    Clin Microbiol Rev; 2010 Jan; 23(1):160-201. PubMed ID: 20065329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance.
    Kang SJ; Kim DH; Lee BJ
    Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Lactamases: A Focus on Current Challenges.
    Bonomo RA
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.